High levels of VEGF-A in tumors and blood samples from STS patients are associated with a higher tumor grade, an increased tendency to form metastases, a reduced response to treatment, a lower overall survival, and an increased risk of recurrence [26]. Here, VEGFA is linked to neoplasm.